EMBO Molecular Medicine

 Closeup
In a flurry of PINK, mitochondrial bioenergetics takes a leading role in Parkinson's disease
Anne N. Murphy *
Department of Pharmacology, MC 0636, Basic Sciences Building, Rm 3014, 9500 Gilman Dr., La Jolla, University of California, San Diego, CA 92093, USA
email: Anne N. Murphy (anmurphy@ucsd.edu)

*Correspondence to Anne N. Murphy, Tel: 858-246-0573; Fax: 858-822-0041

Associate Professor.

Keywords
complex I • PINK1 • mitochondrial respiration

Abstract
For many years research in Parkinson's disease (PD) has linked mitochondrial dysfunction with the characteristic loss of dopaminergic neurons of the substantia nigra, accumulation of cytoplasmic inclusions termed Lewy bodies, and motor dysfunction (Henchcliffe & Beal, [2008]). The most compelling connection is that Parkinsonism can be observed in both humans and animals following exposure to inhibitors of complex I of the electron transport chain (Betarbet et al, [2002]).

Digital Object Identifier (DOI)

10.1002/emmm.200900020  About DOI

Search the Site

Search

Site Adverts